Immutep IMMP
NASDAQ IMMP
$3.56 +0.10 (+2.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Immutep (IMMP) Change in Accrued Expenses (2011 - 2018)

Updated

Analysis

Immutep (IMMP) Change in Accrued Expenses (2011 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immutep 252.65 Mn 41.62 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 119,680.72
Jun 30, 2017 -5,348.62
Jun 30, 2016 -33,724.81
Jun 30, 2015 -277.54
Jun 30, 2014 74,432.89
Jun 30, 2013 -88,342.67
Jun 30, 2012 55,733.97
Jun 30, 2011 44,789.25
API Access

Immutep Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMMP&period=max&api_key=YOUR_API_KEY